{
  "main_header": {
    "sid": 1000979,
    "name": "Zim Laboratories",
    "stock_name": "Zim Laboratories",
    "full_name": "Zim Laboratories Ltd",
    "name_url": "stocks-analysis/zim-laboratories",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "67.00",
    "chg": 2.88,
    "chgp": "4.49%",
    "dir": 1,
    "prev_price": "64.12",
    "mcapval": "334.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 541400,
    "symbol": "ZIMLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE518E01015",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "67.3 k",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/zim-laboratories-1000979-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 485,
    "sid": "1000979",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/zim-laboratories-1000979"
  },
  "announcements": [
    {
      "caption": "Intimation Of Appointment Of Internal Auditor Of The Company",
      "datetime": "30-Mar-2026",
      "details": "The disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 regarding the appointment of Grant Thornton Bharat LLP as the Internal Auditors of the Company is enclosed herewith.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2026",
      "details": "Please find enclosed the intimation regarding Closure of trading window.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "18-Mar-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mathew Cyriac & PACs",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Zim Laboratories Ltd has declared <strong>5%</strong> dividend, ex-date: 19 Sep 19",
          "dt": "2019-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Zim Laboratories Ltd has announced <strong>2:1</strong> bonus issue, ex-date: 22 Dec 22",
          "dt": "2022-12-22",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News